Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
7. Teleflex nabs Eon Medical, lands E.U. win for Arrow GPSCath catheter
Teleflex acquires late-stage device company Eon Medical for its scar-reducing microlaparoscopy platform and lands European approval for its Arrow GPSCath balloon dilation catheter.
6. GE Healthcare launches $2B software-development program
GE Healthcare is pouring $2 billion into a 5-year program to boost its software for healthcare systems and applications.
5. Can C.R. Bard use a windfall to reignite growth?
Bard’s poor organic growth has kept a lid on the stock when so many other medtechs have enjoyed big runs. Could a patent infringement settlement with Gore help turn the tide?
4. Boston Scientific warns of labeling issues in balloon dilators, catheters
Hong Kong healthcare regulators flag 3 Boston Scientific products over typos in labeling and mismatched products.
3. Covidien CEO Almeida wants more from emerging markets
Covidien is doubling down on emerging markets, expanding an investment program that the company had, at 1 point, thought would be over by the end of 2013.
2. J&J struggles to bring Synthes into the fold
J&J’s Michael Orsinger says the company has a long road ahead in the effort streamline the integration of Synthes, the medical giant’s largest-ever acquisition, which fetched a $19.7 billion price tag.
1. FDA releases full Edwards Lifesciences warning letter
The FDA publishes the May 24 warning letter resulting from a month-long inspection of a Utah manufacturing facility, which resulted in 2 recalls but not much reaction from Wall Street.
Leave a Reply
You must be logged in to post a comment.